Sort
51,593 grants matching “hepatitis”
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis
$590,138David B Agus · University Of Southern California · R01 · FY2013 · CA
Prospective evaluation of outcomes in cirrhosis of different etiologies: impact of HIV infection and simvastatin therapy
$590,081Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2022 · DK
Understanding the pathogenesis of elevated androgen induced metabolic dysfunction in females
$589,996Sheng Wu · Temple Univ Of The Commonwealth · R01 · FY2019 · HD
Corticosteroid Pharmacokinetics and Pharmacodynamics
$589,990William J Jusko · State University Of New York At Buffalo · R37 · FY2009 · GM
Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination
$589,981Janice Y. Tsoh · University Of California, San Francisco · R01 · FY2021 · DA
Unraveling the Complexity of Lipoprotein(a) Metabolism: Human Kinetic Studies
$589,918Gissette Reyes-Soffer · Columbia University Health Sciences · R01 · FY2021 · HL
Cell-cell adhesion-mediated signaling determines epithelial polarization in the liver
$589,839Anne Muesch · Albert Einstein College Of Medicine · R01 · FY2021 · DK
Cell-cell adhesion-mediated signaling determines epithelial polarization in the liver
$589,839Anne Muesch · Albert Einstein College Of Medicine · R01 · FY2020 · DK
Cell-cell adhesion-mediated signaling determines epithelial polarization in the liver
$589,839Anne Muesch · Albert Einstein College Of Medicine · R01 · FY2019 · DK
Multi-modality detection of RCC Recurrence Post Ablation
$589,728John Eisenbrey · Thomas Jefferson University · R01 · FY2025 · CA
Apolipoprotein M: a novel regulator of myocardial Autophagy
$589,712Ali Javaheri · Washington University · R01 · FY2025 · HL
Neutralizing Antibodies to Hepatitis C
$589,711Steven Foung · Stanford University · R01 · FY2008 · HL
Ultrasound System for Transational Research
$589,686Albert J Sinusas · Yale University · S10 · FY2021 · OD
Observation Study of Persons with Chronic Hepatitis B Virus infection in North America
$589,571Harry Janssen · University Health Network · U01 · FY2015 · DK
Therapeutics targeting cathepsin-activated viral entry
$589,497Paul F Bates · University Of Pennsylvania · U01 · FY2006 · AI
NOVEL L-NUCLEOSIDE COMBINATION ANTI-HBV THERAPY
$589,490Idenix Pharmaceuticals · R44 · FY2001 · AI
Physiology of Lipid Droplets and Triglyceride Storage
$589,475Robert V Farese · Harvard School Of Public Health · R01 · FY2015 · DK
"A microbiome-dependent bile acid metabolite improves type 2 diabetes."
$589,392Eric Garland Sheu · Brigham And Women'S Hospital · R01 · FY2025 · DK
TREAT-Mayo
$589,343Vijay H Shah · Mayo Clinic Rochester · U01 · FY2014 · AA
Lymphatics in the liver
$589,312Yasuko Iwakiri · Yale University · R01 · FY2023 · DK
HIV-Hepatitis C Virus Cooperative Interactions and Liver Disease Progression
$589,282Raymond T Chung · Massachusetts General Hospital · R01 · FY2016 · DK
Programmed Differentiation Circuits for Organoids using Meso-Microfluidics
$589,257Peter Andrew Carr · Massachusetts Institute Of Technology · R01 · FY2021 · EB
Congenital CMV and CNS Infection Mechanisms of Protective Immunity
$589,230William J Britt · University Of Alabama At Birmingham · R01 · FY2011 · AI
Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC)
$589,199Mai Tuyet Pho · University Of Chicago · UG3 · FY2017 · DA
Regulation of cardiomyocyte differentiation from human embryonic stem cells
$589,199Alan Michelson · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL